IP Library Granted Patent US 6,872,307
Granted Patent B2
US 6,872,307 · App. 10/430,785 · Granted Mar 29, 2005

Systems and methods for on line finishing of cellular blood products like platelets harvested for therapeutic purposes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,872,307
App. No.
10/430,785
Granted
Mar 29, 2005
Kind
B2
Abstract

Blood processing systems and methods establish on line communication between a container and a source of blood containing leukocytes and platelets, such as a human donor. The systems and methods create a centrifugal field between the source of blood and the container that separates from the blood an unfinished suspension of platelets having a first physiologic characteristic different than the desired physiologic characteristic. The systems and methods pump the unfinished platelet suspension outside the centrifugal field through a finishing device. The finishing device changes the first physiologic characteristic to the desired physiological characteristic, thereby creating the finished platelet suspension. The systems and methods convey the finished platelet suspension from the finishing device directly into the container. The systems and methods function without interrupting the on line communication between the container and the source of blood.

Claims (6)

1. A blood processing system comprising

a storage container,

a centrifugal separation device that, in use, creates a centrifugal field that separates from blood a suspension of platelets having a first leukocyte concentration that is higher than a desired leukocyte concentration, the centrifugal field creating pressure,

a finishing device communicating with the centrifugal separation device outside the centrifugal field that, upon contact with the suspension of platelets having the first leukocyte concentration, reduces the leukocyte concentration to the desired leukocyte concentration, thereby creating a finished platelet suspension, and

a pump between the centrifugal separation device and the finishing device that, in use, pumps the suspension of platelets having the first leukocyte concentration from the centrifugal separation device directly through the finishing device under pressure from the centrifugal field and

that conveys the finished platelet suspension from the finishing device directly into the storage container.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2012
From: MORGAN STANLEY & CO. LLC
To: FENWAL, INC.; FENWAL HOLDINGS, INC.
Reel/Frame 029480/0549 →
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2012
From: MORGAN STANLEY & CO. LLC
To: FENWAL, INC.; FENWAL HOLDINGS, INC.
Reel/Frame 029480/0597 →
SECOND-LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 15, 2007
From: FENWAL, INC.; FENWAL HOLDINGS, INC.
To: MORGAN STANLEY & CO. INCORPORATED
Reel/Frame 019297/0168 →
FIRST-LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 11, 2007
From: FENWAL, INC.; FENWAL HOLDINGS, INC.
To: MORGAN STANLEY & CO. INCORPORATED
Reel/Frame 019280/0211 →
PATENT ASSIGNMENT Recorded Apr 6, 2007
From: BAXTER INTERNATIONAL INC.
To: FENWAL, INC.
Reel/Frame 019129/0001 →